Free Trial
NASDAQ:MGRM

Monogram Orthopaedics Q2 2024 Earnings Report

Monogram Orthopaedics logo
$5.72 -0.02 (-0.35%)
Closing price 04:00 PM Eastern
Extended Trading
$5.68 -0.04 (-0.79%)
As of 06:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Monogram Orthopaedics EPS Results

Actual EPS
-$0.11
Consensus EPS
-$0.09
Beat/Miss
Missed by -$0.02
One Year Ago EPS
-$0.27

Monogram Orthopaedics Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Monogram Orthopaedics Announcement Details

Quarter
Q2 2024
Time
After Market Closes
Conference Call Date
Wednesday, August 14, 2024
Conference Call Time
4:30PM ET

Upcoming Earnings

Monogram Orthopaedics' Q2 2025 earnings is scheduled for Wednesday, August 13, 2025, with a conference call scheduled on Friday, August 8, 2025 at 9:30 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.

Monogram Orthopaedics Earnings Headlines

The End of Elon Musk…?
The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again. And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again. According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime.
See More Monogram Orthopaedics Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Monogram Orthopaedics? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Monogram Orthopaedics and other key companies, straight to your email.

About Monogram Orthopaedics

Monogram Orthopaedics (NASDAQ:MGRM), Inc. focuses on developing a product solution architecture to enable patient-optimized orthopaedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures. Its robot prototype executes optimized paths for high-precision insertion of optimized implants in synthetic bone specimens. The company was formerly known as Monogram Arthroplasty Inc. and changed its name to Monogram Orthopaedics, Inc. in March 2017. The company was founded in 2015 and is headquartered in Austin, Texas.

View Monogram Orthopaedics Profile

More Earnings Resources from MarketBeat